Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Mylan Receives FDA Approval For Generic Version Of Thyroid Deficiency Treatment Cytomel(R)
Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Liothyronine Sodium Tablets USP, 5 mcg (base), 25 mcg (base) and 50 mcg (base).
generic viagra online
Bird Flu Virus Remains Infectious Up To 600 Days In Municipal Landfills
Amid concerns about a pandemic of swine flu, researchers from Nebraska report for the first time that poultry carcasses infected with another threat - the "bird flu" virus - can remain infectious in municipal landfills for almost 2 years. Their report is scheduled for the June 15 issue of ACS" semi-monthly journal Environmental Science & Technology.
News of the day
Washington Post Examines Future Of USAID, Foreign Policy Reports Farmer No Longer Under Consideration For Agency Top Spot
USAID, "the main U.S. foreign aid agency is in limbo, entering its seventh month without a permanent director despite pledges by the Obama administration to expand development assistance and improve its effectiveness in poor countries," the Washington Post reports in an article examining the agency"s prospects and concerns that changes could reduce its clout. "While [Secretary of State Hillary Rodham] Clinton has championed additional personnel for USAID, aid groups worry that the once-autonomous agency could be swallowed up in the State Department, with long-term development goals losing out to short-term political aims," the Washington Post writes. The article includes comments from development experts and administration officials on USAID"s future.
Health Insurance

FDA Approves Expanded Use Of HIV Drug

Merck announced on Thursday that the FDA has approved expanded use of its HIV drug, Isentress, Reuters reports (Pierson, 7/9). Isentress has been FDA-approved since 2007, but was limited "to use in patients who had drug-resistant strains or were failing on other therapies, also in combination with other HIV drugs. Now it can be used in all adult patients," the AP/CNBC.com reports. According to AP/CNBC.com, "Isentress is an integrase inhibitor, meaning it works by blocking the enzyme integrase, one of three types of enzymes the AIDS virus uses to reproduce and infect cells" (7/9). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009